China's three major stock indices closed higher today (March 6), with the Shanghai Composite Index up 0.38%, the Shenzhen Component Index rising 0.59%, and the ChiNext Index gaining 0.38%. Total trading volume across Shanghai, Shenzhen, and Beijing markets reached 2.22 trillion yuan. More than 4,200 stocks advanced in the broader market.

The agricultural sector saw another strong surge, with YASHA Group and Dunhuang Seed Industry both hitting their daily limit-up. The market's only agriculture, animal husbandry, and fishery ETF (159275) soared 4.14% to close at a record high since its listing. The pharmaceutical sector also performed strongly, with the sole pharmaceutical ETF (562050) rising 3.15%. The fintech sector experienced rare significant movement, with the Financial Technology ETF (159851) closing up 2.67%.

Hong Kong markets demonstrated broad-based strength today, led by innovative drug stocks. The Hong Kong Stock Connect Innovative Drug ETF (520880), which focuses exclusively on innovative drug research companies, continued its upward trend with a 4.27% gain, accumulating over 7% in two days. Technology stocks showed strong rebound, with the Hong Kong Internet ETF (513770), representing core AI assets in Hong Kong, surging 2.49%. The market's first ETF focusing on Hong Kong's chip industry chain, the Hong Kong Information Technology ETF (159131), closed up more than 1%.

Looking ahead, China Galaxy Securities noted that 2026 marks the beginning of the 15th Five-Year Plan period. As seasonal factors from the Spring Festival fade, domestic markets will be influenced by policy implementation, liquidity support, and industry trends. Market trading styles may exhibit dispersed characteristics with "policy hotspot rotation and rapid style switching," as trading logic shifts from policy expectations and thematic speculation to earnings realization. Currently, geopolitical conflicts have significantly driven up oil prices and shipping costs, but their impact on broad market indices remains limited, with medium to long-term trends likely showing震荡上行.

Huafu Securities indicated that at the index level, the macroeconomic environment of range-based regulation and target management helps reduce market uncertainty premiums, potentially maintaining risk appetite at medium to high levels. Structurally, they recommend focusing on three main themes: intelligent economy, future energy and materials, and consumption and livelihood.

Turning to specific sector ETFs, the innovative drug sector demonstrated strong performance. The high-beta Hong Kong Stock Connect Innovative Drug ETF (520880) surged over 7% in two days, supported by multiple positive factors including business development and earnings. With biopharmaceuticals designated as an "emerging pillar industry," A+H pharmaceutical assets received significant boosts. The ETF gained 4.27% today, with billion-level funds positioning in advance over the past five days. The Pharmaceutical ETF (562050), heavily weighted in A-share innovative drugs, rose 3.15% for three consecutive gaining sessions.

The healthcare sector also showed active trading, with CXO, brain-computer interface, and AI healthcare concepts rising together. The largest healthcare ETF (512170) and the Hong Kong Stock Connect Healthcare ETF Huabao (159137), useful for T+0 trading, both gained over 2%, ending four consecutive days of declines.

All 37 constituent stocks of the Hong Kong Stock Connect Innovative Drug ETF (520880) advanced, with JT Pharmaceutical-B skyrocketing 43.53%, Rongchang Biotechnology rising nearly 11%, and Sansheng Pharmaceutical and KeyMed-B both gaining over 9%.

Policy support served as a key catalyst. This year's government work report for the first time explicitly listed biopharmaceuticals as a national-level "emerging pillar industry," alongside integrated circuits, aerospace, and low-altitude economy. This designation signals important policy support for accelerated industry upgrading.

Additional industry positives include overseas business development, with innovative drug BD total packages exceeding $50 billion in the first two months, approaching 40% of the full-year 2025 figure. On the earnings front, several innovative drug leaders including BeiGene and Rongchang Biotechnology pre-announced positive results, with institutions suggesting that subsequent earnings realization could further catalyze the sector.

From an investment timing perspective, the Hong Kong Stock Connect innovative drug sector entered a correction phase last September, lasting nearly six months, making current levels attractive for allocation.

The agriculture, animal husbandry, and fishery sector saw another strong advance. The market's only Agriculture, Animal Husbandry, and Fishery ETF (159275) moved higher throughout the day, closing up 4.14% at a new record high since listing.

Seed industry and planting stocks led gains, with YASHA Group and Dunhuang Seed Industry both limit-up, COFCO Tech and Xiangjia股份 surging over 7%, and Lihua股份, Julong Animal Husbandry, and Bangji Technology rising more than 5%.

Geopolitical conflicts affecting the Strait of Hormuz have disrupted global bulk fertilizer trade. Rising oil prices directly increase costs for fertilizers, pesticides, and other agricultural inputs. Analysis suggests commodities are entering the final stage of a rotation pattern: "precious metals move first - copper confirms - oil ignites - agriculture concludes," with agricultural products transitioning from "passive transmission" to dual drivers of "cost push + safe-haven allocation."

Regarding the pig farming segment, Shanxi Securities noted the industry may face pressure in the first half of the year, but this period also presents a good window for capacity reduction. As the industry overall still needs to reduce debt and repair balance sheets, persistently low prices could further aid market-driven capacity reduction. Guided by "anti-involution" policies in the pig industry, policy-regulated capacity reduction is also progressing.

Valuation-wise, the agriculture, animal husbandry, and fishery sector remains at relatively low levels, potentially offering good allocation opportunities. Data shows that as of yesterday's close (March 5), the price-to-book ratio of the CSI All Share Agriculture, Animal Husbandry, and Fishery Index, tracked by the unique ETF (159275), was 2.54 times, at the 29.13 percentile over the past five years, highlighting medium to long-term allocation value.

Looking forward, Galaxy Securities pointed out that important meetings mentioned "strengthening implementation of the new round of 100-billion-jin grain production capacity enhancement action" and "high-standard farmland construction." Against this backdrop, opportunities may lie in agricultural technology application and seed technology transformation, suggesting focus on leading seed industry companies.

For comprehensive exposure to the agriculture, animal husbandry, and fishery industry chain, attention turns to the market's only Agriculture, Animal Husbandry, and Fishery ETF (159275). According to China Securities Index Company data, this ETF tracks the CSI All Share Agriculture, Animal Husbandry, and Fishery Index. Its top holdings include industry leaders like Muyuan Foods and Wens Foodstuff Group in pig farming, while also covering major sub-sectors such as feed, grain planting, and animal healthcare. Off-market investors can access the sector through the ETF's feeder funds (Class A 013471 / Class C 013472).

Hong Kong's technology sector experienced a major breakout. The Hang Seng Tech Index surged 3.15% at the close, with internet leaders collectively advancing. Alibaba-W, Xiaomi Corporation-W, Tencent Holdings, Meituan-W, and Kuaishou-W all gained over 3%. The Hong Kong Internet ETF (513770), representing core AI assets in Hong Kong, ended its consecutive decline, jumping 2.49% to reclaim its 5-day moving average.

Several factors previously pressuring Hang Seng Tech showed signs of easing. Regarding overseas liquidity, the Federal Reserve's total assets expanded to $6.6289 trillion yesterday, increasing by $15 billion from the previous day. Overnight reverse repo operations also expanded by nearly $2 billion. The US leveraged loan index rebounded for two consecutive days.

Meanwhile, impressive earnings from internet companies significantly alleviated concerns about substantial AI investments. Bilibili achieved its first annual profit in 2025 with adjusted net profit reaching 2.588 billion yuan, with AI-related content becoming one of the fastest-growing categories. JD Health's 2025 net profit surged 36%, marking a historical high, with AI-powered medical services showing significant results.

Before this rebound began, Hong Kong stocks, particularly Hang Seng Tech, reached a "peak panic" moment. Focusing on the weighted internet sector, as of March 5, the Hong Kong Stock Connect Internet Index had fallen nearly 30% since October 2025, with sector valuations retreating to around the 5.38 percentile over the past five years, suggesting safe-haven pricing may be nearing saturation.

2026 is a crucial year for AI's transition from "concept speculation" to "earnings realization." As major participants and beneficiaries in the AI wave, internet giants' value anchors may shift towards AI infrastructure and service providers, potentially adding elasticity to their valuations as tech assets.

To capture opportunities in the 2026 AI commercialization元年, focus on core Hong Kong AI tools. The Hong Kong Internet ETF (513770) and its feeder funds (Class A 017125; Class C 017126) track the CSI Hong Kong Stock Connect Internet Index. Its top holdings aggregate tech giants like Alibaba-W, Tencent Holdings, Xiaomi Corporation-W, Kuaishou-W, Bilibili-W, and AI application companies across various sectors, offering significant龙头 advantages, T+0 trading capability, and good liquidity.

For investors bullish on Hong Kong tech but seeking lower volatility, consider the market's first Hong Kong Large Cap 30 ETF (520560), featuring a "tech + dividend" barbell strategy. Its heavyweights include high-beta tech stocks like Alibaba and Tencent Holdings, alongside stable high-dividend names like China Construction Bank and Ping An Insurance, making it an ideal core holding for long-term Hong Kong allocation.